The present invention relates to a pharmaceutical formulation of solid dosageforms comprising a therapeuticallyeffective amount of a selective estrogen receptor modulator, and especiallyRaloxifene or a pharmaceutical acceptable salt thereof,in combination with a super disintegrant such as Primojel, and a process forthe preparation thereof by wet granulation.